Focal Segmental GlomerulosclerosisPhase 3NCT07220083

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

A Phase 3 study testing BI 764198 in people with Focal Segmental Glomerulosclerosis, run by Boehringer Ingelheim at 316 sites in 40 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts

Official record

Search all trials

Trial summary

PODOMOUNT-pFSGS This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 helps people with FSGS. Participants are put into 2 groups randomly, which means by chance. Read more about this study

Who is it for?: Ages 12 years and older
Conditions the study is for: Focal Segmental Glomerulosclerosis
What is being tested?: BI 764198
Could I receive a placebo?: Yes, some participants may receive a placebo
How many people: 286 participants
Where: 316 sitesin 40 countries
Study dates: 16 Feb 2026to 24 Jan 2029
Phase: Phase 3
Are there results?: Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 12 years and older
All sexes
No healthy volunteers
Child, Adult, Older adult

Who may be able to join

Male or female participants ≥12 years old on the day of signing informed consent/assent (Visit 1)
Weight of ≥40 kg at the screening visit (Visit 1)
Body mass index (BMI) of ≤40 kg/m² at the screening visit (Visit 1)
Participants with a diagnosis prior to the screening visit (Visit 1) of either:
Biopsy-confirmed primary focal segmental glomerulosclerosis (pFSGS) (based on Investigator's judgement) OR
Genetic focal segmental glomerulosclerosis (FSGS) resulting from a gain-of-function mutation in the transient receptor potential cation subfamily C member 6 (TRPC6) gene (based on historical genetic test)

Show all 10Show fewer

Urine protein-creatinine ratio (UPCR) ≥1500 mg/g based on the mean of the spot urine sample and first morning void (FMV) urine sample (both assessed by central laboratory) at the screening visit (Visit 1)
Estimated glomerular filtration rate (eGFR)
For adult participants (≥18 years): ≥25 mL/min/1.73 m² (chronic kidney disease epidemiology collaboration (CKD-EPI) formula based on serum cystatin C) at the screening visit (Visit 1)
For adolescent participants (12 to <18 years): ≥25 mL/min/1.73 m² based on chronic kidney disease under 25 years (CKiD U25) formula using serum cystatin C at the screening visit (Visit 1) Further inclusion criteria apply.

Who cannot join

Known monogenic or syndromic causes of FSGS (with the exception of TRPC6 gain-of-function gene mutations)
Clinical or histologic evidence of secondary adaptive or toxic forms of FSGS (based on Investigator's judgement)
FSGS of undetermined cause (FSGS-UC) with a diagnosis prior to the screening visit (Visit 1) (based on Investigator's judgement)
A history of organ transplantation or planned organ transplantation during the course of the trial
Use of intravenous immunosuppressive agents (e.g. cyclophosphamide, rituximab, obinutuzumab) in the last 6 months prior to screening (Visit 1) Further exclusion criteria apply.

Trial locations and contacts

316 sites in 40 countries. Contact the study team or a site near you to ask about taking part.

Boehringer Ingelheim contact

1-800-243-0127

clintriage.rdg@boehringer-ingelheim.com

Country

City, postcode or hospital

Sites recruiting now only

316 sites in 40 countries

United States77 sites, 77 recruiting

Alabama Kidney Research
Alabaster, Alabama, 35007
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Texas Tech University Health Sciences Center-Amarillo-63885
Amarillo, Texas, 79106
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Virginia Nephrology
Arlington, Virginia, 22205
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Emory Children's Center
Atlanta, Georgia, 30322
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Johns Hopkins Hospital
Baltimore, Maryland, 21287
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Renal Associates of Baton Rouge
Baton Rouge, Louisiana, 70808
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Northeast Clinical Research Center
Bethlehem, Pennsylvania, 18017
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Florida Kidney Physicians - Boca Raton
Boca Raton, Florida, 33487
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Joslin Diabetes Center
Boston, Massachusetts, 02215
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Coastal Medical Research, LLC
Brunswick, Georgia, 31520
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Americare Kidney Institute - Brunswick
Brunswick, Ohio, 44212
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Southeast Renal Research Institute
Chattanooga, Tennessee, 37404
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Northwestern University
Chicago, Illinois, 60611
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
The Kidney and Hypertension Center
Cincinnati, Ohio, 45212
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Elixia MNA, LLC
City of Saint Peters, Missouri, 63376
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
New York Nephrology and Dialysis Access Surgery, PC
Clifton Park, New York, 12065
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Nephrology Associates - Columbus
Columbus, Mississippi, 39705
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Nationwide Children's Hospital
Columbus, Ohio, 43205
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
The Healing Kidneys Institute
Conroe, Texas, 77304
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Advanced Dallas Hospital and Clinics
Dallas, Texas, 75231
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Nephrotex Research Group
Dallas, Texas, 75231
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Kidney Associates of Colorado - Denver
Denver, Colorado, 80210
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Colorado Kidney Care
Denver, Colorado, 80220
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Henry Ford Hospital
Detroit, Michigan, 48202
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Duke University Medical Center
Durham, North Carolina, 27710
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Southeast Kidney Associates - East Point
East Point, Georgia, 30344
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Nephrology Associates, Inc
East Providence, Rhode Island, 02914-2641
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Endeavor Health
Evanston, Illinois, 60201
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Clinical Renal Associates
Exton, Pennsylvania, 19341
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Nephrology Associates of Northern Virginia
Fairfax, Virginia, 22150
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Florida Kidney Physicians, LLC - Fort Lauderdale
Fort Lauderdale, Florida, 33316
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
West Coast Kidney Institute
Fremont, California, 94538
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
University of Texas Medical Branch at Galveston
Galveston, Texas, 77555
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Kidney Disease Medical Group
Glendale, California, 91206
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Amicis Research Center - Balboa
Granada Hills, California, 91344
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Sanmora Bespoke Clinical Research Solutions
Grand Prairie, Texas, 75051
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Carolina Kidney Associates
Greensboro, North Carolina, 27405-3654
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Provecta Researh Network
Houston, Texas, 77027
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Provecta Research Path Forward Ventures
Humble, Texas, 77338
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Valiance Clinical Research
Huntington Park, California, 90255
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Apogee Clinical Research
Huntsville, Alabama, 35805
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Paragon Health Nephrology Center - Kalamazoo
Kalamazoo, Michigan, 49007
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
EmVenio Research Inc. - Kansas City
Kansas City, Kansas, 66112
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
DaVita Clinical Research-Las Vegas-67781
Las Vegas, Nevada, 89107
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Academic Medical Research Institute - Glendale
Los Angeles, California, 90022
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Kaiser Permanente - Los Angeles Medical Center
Los Angeles, California, 90027
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
University of California Los Angeles
Los Angeles, California, 90095
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Total Research Group, LLC
Miami, Florida, 33126
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
NYU Langone Nephrology Associates-Mineola
Mineola, New York, 11501
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Nephrology Physicians - Mishawaka
Mishawaka, Indiana, 46545
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
West Virginia University Medicine
Morgantown, West Virginia, 26506
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Valley Renal Medical Group - Northridge
Northridge, California, 91324
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Kidney Care Center - Olympia Fields
Olympia Fields, Illinois, 60461
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Palmetto Nephrology
Orangeburg, South Carolina, 29118
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
CTR Oakwater, LLC
Orlando, Florida, 32806
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania, 19104
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Coastal Nephrology and Associates
Port Charlotte, Florida, 33952
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Shasta Critical Care Specialists
Redding, California, 96001
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Virginia Commonwealth University
Richmond, Virginia, 23298
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Florida Kidney Physicians - Riverview/Brandon
Riverview, Florida, 33578
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Primary Children's Hospital
Salt Lake City, Utah, 84113
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Utah Kidney Research Institute
Salt Lake City, Utah, 84115
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
North America Research Institute
San Dimas, California, 91773
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Kaiser Permanente - French Campus
San Francisco, California, 94118
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Memorial Health University Hospital
Savannah, Georgia, 31404
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Cardinal Clinical Research, LLC - Shelby
Shelby, North Carolina, 28150
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Northwest Louisiana Nephrology
Shreveport, Louisiana, 71101
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Southwest Kidney Institute
Surprise, Arizona, 85374-4840
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Valiance Clinical Research-Tarzana-68237
Tarzana, California, 91356
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
Nephrology & Hypertension Associates, Ltd.
Tupelo, Mississippi, 38801
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
St. Clair Nephrology Research, LLC - Shelby Township
Utica, Michigan, 48315
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
National Institute of Clinical Research - Victorville
Victorville, California, 92392
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting
George Washington University Medical Faculty Associates
Washington D.C., District of Columbia, 20037
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Not yet recruiting
Wichita Nephrology Group
Wichita, Kansas, 67214
Boehringer Ingelheim, 833-602-2368, unitedstates@bitrialsupport.com
Recruiting

Other trials in United States

China22 sites, 22 recruiting

The First Affiliated Hospital of Baotou Medical College
Baotou, 014010
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
Peking University First Hospital
Beijing, 100034
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
Beijing Tsinghua Changgung Hospital
Beijing, 102218
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
The Second Hospital of Jilin University
Changchun, 130041
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
The Second Xiangya Hospital Of Central South University
Changsha, 410011
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
West China Hospital, Sichuan University
Chengdu, 610041
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
Sichuan Provincial People's Hospital
Chengdu, 610072
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
Guangdong Provincial People's Hospital
Guangzhou, 510080
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
The First Affiliated Hospital, Zhejiang University
Hangzhou, 310003
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
Lanzhou University Second Hospital
Lanzhou, 730030
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, 330006
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
Zhongda Hospital Southeast University
Nanjing, 210009
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
The First People's Hospital of Nanning
Nanning, 530000
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
The First Affiliated Hospital of Guangxi Medical University
Nanning, 530021
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
The First Affiliated Hospital of Ningbo University
Ningbo, 315010
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Not yet recruiting
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, 200025
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
Huashan Hospital, Fudan University
Shanghai, 200040
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
Shanghai General Hospital
Shanghai, 200080
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
Shanxi Provincial People's Hospital
Taiyuan, 030000
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
Renmin Hospital of Wuhan University
Wuhan, 430060
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
First Affiliated Hospital of Xi'an JiaoTong University
Xi'an, 710061
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting
Zhongshan Hospital Affiliated to Xiamen University
Xiamen, 361004
Boehringer Ingelheim, 4001200553, china@bitrialsupport.com
Recruiting

Other trials in China

India19 sites, 19 recruiting

Aartham Multi Super Speciality Hospital
Ahmedabad, 380015
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Recruiting
Zydus Hospital - Ahmedabad
Ahmedabad, 380054
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Not yet recruiting
AIIMS Bhubaneshwar
Bhubaneswar, 751019
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Not yet recruiting
S.P. Medical College & Associated Group of Hospitals
Bikaner, 334003
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Recruiting
Madras Medical College and Rajiv Gandhi Government General Hospital
Chennai, 600032
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Not yet recruiting
Sri Ramchandra Institute
Chennai, 600116
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Not yet recruiting
Shri Mahant Indiresh Hospital
Dehradun, 248001
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Recruiting
Sir Gangaram Hospital
Delhi, 110060
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Not yet recruiting
Osmania Medical College & Hospital
Hyderabad, 500012
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Recruiting
Nizam's Institute of Medical Sciences
Hyderabad, 500082
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Recruiting
Government Medical College
Kozhikode, 673008
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Not yet recruiting
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Lucknow, 226014
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Not yet recruiting
Kasturba Medical College and Hospital
Manipal, 576104
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Not yet recruiting
Nutema Hospital
Meerut, 250004
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Recruiting
KEM Hospital and Seth G S Medical College
Mumbai, 400012
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Not yet recruiting
P.D. Hinduja National Hospital
Mumbai, 400016
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Not yet recruiting
Noble Hospital Pvt Ltd
Pune, 411013
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Recruiting
Galaxy Lifecare Services Pvt. Ltd.
Varanasi, 201010
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Recruiting
Sunrise Hospital
Vijayawada, 520002
Boehringer Ingelheim, 0008000501442, india@bitrialsupport.com
Not yet recruiting

Other trials in India

Japan19 sites, 19 recruiting

Kasugai Municipal Hospital
Aichi, Kasugai, 486-8510
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
Daido Clinic
Aichi, Nagoya, 457-8511
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital
Aichi, Nagoya, 466-8650
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
Chiba University Hospital
Chiba, Chiba, 260-8677
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
National Hospital Organization Chibahigashi National Hospital
Chiba, Chiba, 260-8712
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
Japanese Red Cross Fukuoka Hospital
Fukuoka, Fukuoka, 815-8555
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
Kurume University Hospital
Fukuoka, Kurume, 830-0011
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
Kobe University Hospital
Hyogo, Kobe, 650-0017
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
Saiseikai Yokohamashi Nanbu Hospital
Kanagawa, Yokohama, 234-0054
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
Yokohama City University Hospital
Kanagawa, Yokohama, 236-0004
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
Nara Prefecture General Medical Center
Nara, Nara, 630-8581
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Not yet recruiting
Niigata University Medical and Dental Hospital
Niigata, Niigata, 951-8520
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
Kawasaki Medical School Hospital
Okayama, Kurashiki, 701-0192
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Not yet recruiting
Okayama University Hospital
Okayama, Okayama, 700-8558
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Not yet recruiting
Dokkyo Medical University Saitama Medical Center
Saitama, Koshigaya, 343-8555
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
Institute of Science Tokyo Hospital
Tokyo, Bunkyo-ku, 113-8519
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
Tokyo Medical University Hachioji Medical Center
Tokyo, Hachioji, 193-0998
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
The Jikei University Hospital
Tokyo, Minato-ku, 105-8471
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting
Tokyo Women's Medical University Hospital
Tokyo, Shinjuku-ku, 162-8666
Boehringer Ingelheim, 05050508862, nippon@bitrialsupport.com
Recruiting

Other trials in Japan

Turkey (Türkiye)11 sites, 11 recruiting

Adana City Hospital
Adana, 01220
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
Recruiting
Ankara Etlik City Hospital
Ankara, 06200
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
Recruiting
Malatya Inonu University Hospital
Battalgazi / Malatya, 44280
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
Not yet recruiting
Bursa Uludag University
Bursa, 16110
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
Recruiting
Istanbul Capa University
Istanbul, 34093
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
Recruiting
Istanbul Universitesi Cerrahpasa Tip Fakultesi
Istanbul, 34098
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
Not yet recruiting
Kocaeli University Faculty of Medicine Hospital
İzmit, 41000
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
Recruiting
Erciyes University
Melikgazi/Kayseri, 38039
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
Recruiting
Afyon Kocatepe University Hospital
Merkez / Afyonkarahisar, 03100
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
Not yet recruiting
Mersin University Medical Faculty
Mersin, 33110
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
Not yet recruiting
Sakarya Üniversitesi Tıp Fakültesi
Sakarya, 54187
Boehringer Ingelheim, 08006212470, turkiye@bitrialsupport.com
Not yet recruiting

Other trials in Turkey (Türkiye)

Portugal10 sites, 10 recruiting

ULS de Almada -Seixal, E. P. E. - Hospital Garcia de Orta
Almada, 2801-951
Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com
Recruiting
ULS de Amadora/ Sintra, E.P.E. - Hospital Professor Doutor Fernando Fonseca
Amadora, 2720-276
Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com
Not yet recruiting
ULS de Braga, E.P.E
Braga, 4710-243
Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com
Recruiting
CHUC - Centro Hospitalar e Universitario de Coimbra, EPE
Coimbra, 3004-561
Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com
Recruiting
ULS de São José
Lisbon, 1069-166
Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com
Recruiting
ULS de Santa Maria, E.P.E
Lisbon, 1649-035
Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com
Recruiting
Unidade Local de Saúde Lisboa Occidental, E.P.E
Lisbon, 2790-134
Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com
Recruiting
ULS de Loures-Odivelas, E.P.E
Loures, 2674-514
Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com
Recruiting
ULS de Santo Antônio, E.P.E - Centro Hospitalar Universitário de Santo António
Porto, 4099-001
Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com
Recruiting
Unidade Local de Saúde da Arrábida,E.P.E
Setúbal, 2910-549
Boehringer Ingelheim, 800856070, portugal@bitrialsupport.com
Recruiting

Other trials in Portugal

Argentina9 sites, 9 recruiting

Terapia Renal Domiciliaria
Buenos Aires, 1407
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
Recruiting
Hospital Italiano de Buenos Aires
CABA, C1199ABB
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
Recruiting
CEMIC
CABA, C1431FWO
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
Recruiting
Centro Medico Dra Laura Maffei
Ciudad Autonoma Buenos Aires, C1425AGC
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
Recruiting
Clinica Privada Velez Sarfield
Córdoba, 5000
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
Recruiting
Hospital Universitario Austral
Pilar, B1629ODT
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
Recruiting
CardioAlem Investigaciones
San Isidro, B1642DCD
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
Recruiting
Centro Integral de Medicina Respiratoria - CIMER
San Miguel de Tucumán, 4000
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
Not yet recruiting
Grupo MIT - Medicina Interdisciplinaria y Trasplantes
Santa Fe, S3000EOM
Boehringer Ingelheim, 08002667801, argentina@bitrialsupport.com
Not yet recruiting

Other trials in Argentina

Australia9 sites, 9 recruiting

Royal Adelaide Hospital
Adelaide, South Australia, 5000
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
Recruiting
Sunshine Hospital
AT Albans, Victoria, 3021
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
Not yet recruiting
Concord Repatriation General Hospital
Concord, New South Wales, 2139
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
Not yet recruiting
Royal Brisbane and Women's Hospital
Herston, Queensland, 4029
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
Recruiting
Nepean Hospital
Kingswood, New South Wales, 2747
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
Recruiting
St George Hospital
Kogarah, New South Wales, 2217
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
Recruiting
Royal Melbourne Hospital
Parkville, Victoria, 3050
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
Recruiting
Griffith Health
Southport, Queensland, 4222
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
Recruiting
The Children's Hospital at Westmead
Westmead, New South Wales, 2145
Boehringer Ingelheim, 1800271035, australia@bitrialsupport.com
Not yet recruiting

Other trials in Australia

France9 sites, 9 recruiting

CHU Amiens-Picardie
Amiens, 80054
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
Recruiting
HOP Pellegrin
Bordeaux, 33076
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
Recruiting
HOP de la Cavale Blanche
Brest, 29200
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
Recruiting
Hopital Henri Mondor
Créteil, 94000
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
Recruiting
Hôpital Edouard Herriot
Lyon, 69437
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
Recruiting
Hopital Pasteur
Nice, 06000
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
Recruiting
CHU de Nîmes
Nîmes, 30029
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
Recruiting
Hopital Necker
Paris, 75015
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
Recruiting
HOP Nancy
Vandœuvre-lès-Nancy, 54500
Boehringer Ingelheim, 0805102354, france@bitrialsupport.com
Recruiting

Other trials in France

Taiwan9 sites, 9 recruiting

Buddhist Tzu Chi General Hospital-Hualien-20741
Hualien City, 970
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
Recruiting
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, 83301
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
Recruiting
Far Eastern Memorial Hospital
New Taipei City, 220
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
Recruiting
Taipei Medical University-Shuang Ho Hospital
New Taipei City, 235
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
Recruiting
China Medical University Hospital
Taichung, 40447
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
Recruiting
Taichung Veterans General Hospital
Taichung, 40705
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
Recruiting
National Cheng Kung University Hospital
Tainan, 70403
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
Recruiting
National Taiwan University Hospital
Taipei, 10048
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
Recruiting
Chang Gung Memorial Hospital, Linkou
Taoyuan City, 333
Boehringer Ingelheim, 0809092098, taiwan@bitrialsupport.com
Recruiting

Other trials in Taiwan

United Kingdom9 sites, 9 recruiting

Clatterbridge Hospital
Bebington, CH63 4JY
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
Recruiting
Bradford Institute for Health Research
Bradford, BD9 6RJ
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
Recruiting
Addenbrooke's Hospital
Cambridge, CB2 0QQ
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
Recruiting
St Helier Hospital
Carshalton, SM5 1AA
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
Recruiting
Leicester General Hospital
Leicester, LE5 4PW
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
Recruiting
Royal Free Hospital
London, NW3 2QG
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
Recruiting
King's College Hospital
London, SE5 9RS
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
Recruiting
The James Cook University Hospital
Middlesbrough, TS4 3BW
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
Not yet recruiting
Salford Royal Hospital
Salford, M6 8HD
Boehringer Ingelheim, 08000514022, unitedkingdom@bitrialsupport.com
Recruiting

Other trials in United Kingdom

Germany8 sites, 8 recruiting

Vivantes Klinikum im Friedrichshain
Berlin, 10249
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
Recruiting
Universitätsklinikum Köln (AöR)
Cologne, 50937
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
Recruiting
Universitätsklinikum Hamburg, Eppendorf
Hamburg, 20246
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
Recruiting
Medizinische Hochschule Hannover
Hanover, 30625
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
Recruiting
Universitätsklinikum Heidelberg
Heidelberg, 69120
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
Recruiting
Universität Leipzig
Leipzig, 04103
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
Recruiting
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Mainz, 55131
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
Recruiting
Universitätsklinikum Würzburg AÖR
Würzburg, 97080
Boehringer Ingelheim, 08007234742, deutschland@bitrialsupport.com
Recruiting

Other trials in Germany

Brazil7 sites, 7 recruiting

Synvia
Campinas, 13087-567
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
Recruiting
Universidade Federal do Ceara
Fortaleza, 60110-110
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
Recruiting
Hospital de Clinicas de Porto Alegre
Porto Alegre, 90035-903
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
Recruiting
Hospital das Clinicas da Universidade Federal de Pernambuco
Recife, 50670-901
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
Recruiting
Fundacao Oswaldo Ramos (Hospital do Rim)
São Paulo, 04038-002
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
Recruiting
Centro de Pesquisa Clínica de Nefrologia do ICHC
São Paulo, 05403-000
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
Recruiting
Instituto da Crianca e do Adolescente
São Paulo, 05403-901
Boehringer Ingelheim, 08008919295, brasil@bitrialsupport.com
Recruiting

Other trials in Brazil

Poland7 sites, 7 recruiting

Promed P.Łach R. Glowacki Sp. j.
Krakow, 31-513
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
Not yet recruiting
Centralny Szpital Kliniczny Uniwersytetu Medycznego w Łodzi
Lodz, 92-213
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
Not yet recruiting
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu
Poznan, 60-355
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
Recruiting
Uniwersytecki Szpital Kliniczny Nr 2 Pum W Szczecinie
Szczecin, 70-111
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
Not yet recruiting
Samodzielny Publiczny Dzieciecy Szpital Kliniczny Im. Jozefa Polikarpa Brudzinskiego W Warszawie
Warsaw, 02-091
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
Not yet recruiting
Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy
Warsaw, 04-141
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
Recruiting
4th Military Clinical Hospital with a Polyclinic
Wroclaw, 50-981
Boehringer Ingelheim, 008001218830, polska@bitrialsupport.com
Not yet recruiting

Other trials in Poland

Spain7 sites, 7 recruiting

Complejo Hospitalario Torrecárdenas
Almería, 04009
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
Recruiting
Hospital del Mar
Barcelona, 08003
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
Recruiting
Hospital Universitari Vall d'Hebron
Barcelona, 08035
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
Recruiting
Hospital Clínic de Barcelona
Barcelona, 08036
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
Recruiting
Hospital Sant Joan de Déu
Barcelona, 08950
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
Recruiting
Hospital Universitario Virgen de las Nieves
Granada, 18014
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
Recruiting
Hospital Universitario 12 de Octubre
Madrid, 28041
Boehringer Ingelheim, 900876092, espana@bitrialsupport.com
Recruiting

Other trials in Spain

Italy6 sites, 6 recruiting

Azienda Universitaria Ospedaliera Consorziale Policlinico Bari
Bari, 70124
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
Recruiting
Policlinico S. Orsola-Malpighi
Bologna, 40138
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
Recruiting
Asst Santi Paolo E Carlo
Milan, 20142
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
Recruiting
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone
Palermo, 90127
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
Recruiting
Fondazione Salvatore Maugeri
Pavia, 27100
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
Recruiting
ASST dei Sette Laghi
Varese, 21100
Boehringer Ingelheim, 800977373, italia@bitrialsupport.com
Not yet recruiting

Other trials in Italy

Malaysia6 sites, 6 recruiting

Hospital Sultan Idris Shah Serdang
Kajang, 43000
Boehringer Ingelheim, 1800814353, malaysia@bitrialsupport.com
Recruiting
Queen Elizabeth Hospital
Kota Kinabalu, 88586
Boehringer Ingelheim, 1800814353, malaysia@bitrialsupport.com
Recruiting
Hospital Kuala Lumpur
Kuala Lumpur, 50586
Boehringer Ingelheim, 1800814353, malaysia@bitrialsupport.com
Recruiting
University Malaya Medical Centre
Lembah Pantai, 59100
Boehringer Ingelheim, 1800814353, malaysia@bitrialsupport.com
Recruiting
Hospital Tuanku Ja'afar
Negeri Sembilan, 70300
Boehringer Ingelheim, 1800814353, malaysia@bitrialsupport.com
Recruiting
Sunway Medical Centre
Subang Jaya, 47500
Boehringer Ingelheim, 1800814353, malaysia@bitrialsupport.com
Recruiting

Other trials in Malaysia

Mexico6 sites, 6 recruiting

Centenario Hospital Miguel Hidalgo
Aguascalientes, 20259
Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com
Not yet recruiting
Health Pharma Professional Research S.A. de C.V.
Mexico City, 03100
Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com
Not yet recruiting
Soltmed Smo
Mexico City, 03650
Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com
Not yet recruiting
Instituto Nacional de Cardiologia Ignacio Chavez
Mexico City, 14080
Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com
Not yet recruiting
Instituto Nacional de Cs Médicas y Nutrición S Zubiran
Mexico City, 14080
Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com
Not yet recruiting
Servicios de Oncología Médica Integral, S.A. de C.V. Sucursal Renal
Monterrey, 64060
Boehringer Ingelheim, 018000623749, mexico@bitrialsupport.com
Not yet recruiting

Other trials in Mexico

South Korea6 sites, 6 recruiting

Pusan National University Hospital
Busan, 49241
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
Recruiting
Samsung Medical Center
Gangnam-gu, 06351
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
Recruiting
Inje University Ilsan Paik Hospital
Goyang, 411 706
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
Recruiting
Severance Hospital
Seoul, 03722
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
Recruiting
Kyung Hee University Hospital at Gangdong
Seoul, 05278
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
Recruiting
Ajou University Hospital
Suwon, 16499
Boehringer Ingelheim, 0808802084, namhan@bitrialsupport.com
Recruiting

Other trials in South Korea

Canada5 sites, 5 recruiting

Victoria Hospital (LHSC)
London, Ontario, N6A 5W9
Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com
Recruiting
Maisonneuve-Rosemont Hospital
Montreal, Quebec, H1T 2M4
Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com
Recruiting
Montreal General Hospital - McGill University Health Centre
Montreal, Quebec, H3G 1A4
Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com
Not yet recruiting
Toronto General Hospital
Toronto, Ontario, M5G 2C4
Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com
Not yet recruiting
BC Children's Hospital
Vancouver, British Columbia, V6H 3N1
Boehringer Ingelheim, 18336022346, canada@bitrialsupport.com
Not yet recruiting

Other trials in Canada

Slovakia5 sites, 5 recruiting

Detska fakultna nemocnica s poliklinikou Banska Bystrica
Banská Bystrica, 97409
Boehringer Ingelheim, 0800002662, slovensko@bitrialsupport.com
Not yet recruiting
Faculty hospital with clinics F.D. Roosevelta
Banská Bystrica, 97409
Boehringer Ingelheim, 0800002662, slovensko@bitrialsupport.com
Not yet recruiting
University Hospital and Comenius University in Bratislava, Derer´s Hospital
Bratislava, 833 05
Boehringer Ingelheim, 0800002662, slovensko@bitrialsupport.com
Not yet recruiting
Univerzitna nemocnica L. Pasteura Kosice
Košice, 040 11
Boehringer Ingelheim, 0800002662, slovensko@bitrialsupport.com
Recruiting
Univerzitna Nemocnica Martin
Martin, 036 01
Boehringer Ingelheim, 0800002662, slovensko@bitrialsupport.com
Recruiting

Other trials in Slovakia

Sweden5 sites, 5 recruiting

Universitetssjukhuset Linköping
Linköping, 581 85
Boehringer Ingelheim, 0200880001, sverige@bitrialsupport.com
Recruiting
Skånes universitetssjukhus
Lund, 221 85
Boehringer Ingelheim, 0200880001, sverige@bitrialsupport.com
Recruiting
Karolinska Universitetssjukhuset
Stockholm, 141 86
Boehringer Ingelheim, 0200880001, sverige@bitrialsupport.com
Recruiting
Danderyds Sjukhus
Stockholm, 182 88
Boehringer Ingelheim, 0200880001, sverige@bitrialsupport.com
Recruiting
Uppsala University Hospital
Uppsala, 751 85
Boehringer Ingelheim, 0200880001, sverige@bitrialsupport.com
Recruiting

Other trials in Sweden

Croatia4 sites, 4 recruiting

University Hospital Dubrava
Zagreb, 10 000
Boehringer Ingelheim, 08007744, hrvatska@bitrialsupport.com
Not yet recruiting
Clinical Hospital Sveti Duh
Zagreb, 10000
Boehringer Ingelheim, 08007744, hrvatska@bitrialsupport.com
Recruiting
Poliklinika Bonifarm Zagreb
Zagreb, 10000
Boehringer Ingelheim, 08007744, hrvatska@bitrialsupport.com
Recruiting
Solmed Polyclinic
Zagreb, 10000
Boehringer Ingelheim, 08007744, hrvatska@bitrialsupport.com
Not yet recruiting

Other trials in Croatia

New Zealand4 sites, 4 recruiting

Optimal Clinical Trials North
Auckland, 0627
Boehringer Ingelheim, 0800440725, newzealand@bitrialsupport.com
Recruiting
New Zealand Clinical Research (NZCR) Christchurch
Christchurch, 8011
Boehringer Ingelheim, 0800440725, newzealand@bitrialsupport.com
Recruiting
Waikato Hospital
Hamilton, Waikato Region, 3204
Boehringer Ingelheim, 0800440725, newzealand@bitrialsupport.com
Recruiting
Taranaki Base Hospital
New Plymouth, 4310
Boehringer Ingelheim, 0800440725, newzealand@bitrialsupport.com
Not yet recruiting

Other trials in New Zealand

Norway4 sites, 4 recruiting

Akershus Universitetssykehus HF
Lørenskog, N-1478
Boehringer Ingelheim, 80058261, norge@bitrialsupport.com
Recruiting
Oslo Universitetssykehus HF, Ulleval sykehus
Oslo, 450
Boehringer Ingelheim, 80058261, norge@bitrialsupport.com
Recruiting
Helse Stavanger, Stavanger Universitetssykehus
Stavanger, 4011
Boehringer Ingelheim, 80058261, norge@bitrialsupport.com
Recruiting
Universitetssykehuset Nord-Norge, Tromso
Tromsø, 9019
Boehringer Ingelheim, 80058261, norge@bitrialsupport.com
Recruiting

Other trials in Norway

Romania4 sites, 4 recruiting

Institutul Clinic Fundeni
Bucharest, 022328
Boehringer Ingelheim, 0800895209, romania@bitrialsupport.com
Recruiting
Spitalul Clinic Judetean de urgenta Cluj
Cluj-Napoca, 400006
Boehringer Ingelheim, 0800895209, romania@bitrialsupport.com
Recruiting
Spitalul Clinic Judetean de Urgenta Bihor
Oradea, 410469
Boehringer Ingelheim, 0800895209, romania@bitrialsupport.com
Not yet recruiting
County Emergency Hospital Pius Brinzeu Timisoara
Timișoara, 300723
Boehringer Ingelheim, 0800895209, romania@bitrialsupport.com
Not yet recruiting

Other trials in Romania

Belgium3 sites, 3 recruiting

AZORG Ziekenhuis
Aalst, 9300
Boehringer Ingelheim, 080049616, belgique@bitrialsupport.com
Recruiting
UZ Leuven
Leuven, 3000
Boehringer Ingelheim, 080049616, belgique@bitrialsupport.com
Recruiting
Centre Hospitalier Universitaire de Liège
Liège, 4000
Boehringer Ingelheim, 080049616, belgique@bitrialsupport.com
Recruiting

Other trials in Belgium

Georgia3 sites, 3 recruiting

LTD Israeli-Georgian Medical Research Clinic Healthycore
Tbilisi, 112
Boehringer Ingelheim, 800008086, sakartvelo@bitrialsupport.com
Recruiting
LEPL The First University Clinic of Tbilisi State Medical University
Tbilisi, 144
Boehringer Ingelheim, 800008086, sakartvelo@bitrialsupport.com
Recruiting
M.Iashvili Children's Hospital
Tbilisi, 159
Boehringer Ingelheim, 800008086, sakartvelo@bitrialsupport.com
Not yet recruiting

Other trials in Georgia

Singapore3 sites, 3 recruiting

National University Hospital
Singapore, 117599
Boehringer Ingelheim, 8001207344, singapore@bitrialsupport.com
Recruiting
Singapore General Hospital
Singapore, 169608
Boehringer Ingelheim, 8001207344, singapore@bitrialsupport.com
Recruiting
Tan Tock Seng Hospital
Singapore, 308433
Boehringer Ingelheim, 8001207344, singapore@bitrialsupport.com
Recruiting

Other trials in Singapore

Bulgaria2 sites, 2 recruiting

Medicinski Centar Hipokrat-N EOOD
Plovdiv, 4000
Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com
Not yet recruiting
Medical Center "Pulmovision"
Sofia, 1756
Boehringer Ingelheim, 024903378, balgariya@bitrialsupport.com
Not yet recruiting

Other trials in Bulgaria

Denmark2 sites, 2 recruiting

Copenhagen University Hospital, Rigshospitalet
København Ø, 2100
Boehringer Ingelheim, 80711822, danmark@bitrialsupport.com
Recruiting
Zealand University Hospita; Roskilde
Roskilde, 4000
Boehringer Ingelheim, 80711822, danmark@bitrialsupport.com
Recruiting

Other trials in Denmark

Finland2 sites, 2 recruiting

New Children's Hospital
Helsinki, 00029 HUS
Boehringer Ingelheim, 0800918118, suomi@bitrialsupport.com
Not yet recruiting
Helsinki University Central Hospital, Meilahti hospital
Helsinki, FI-00290
Boehringer Ingelheim, 0800918118, suomi@bitrialsupport.com
Not yet recruiting

Other trials in Finland

Greece2 sites, 2 recruiting

University General Hospital of Heraklion
Heraklion, 71500
Boehringer Ingelheim, 008000000092, hellas@bitrialsupport.com
Recruiting
Univ. Gen. Hosp. of Patras
Pátrai, 26504
Boehringer Ingelheim, 008000000092, hellas@bitrialsupport.com
Recruiting

Other trials in Greece

Hong Kong2 sites, 2 recruiting

Hong Kong Children's Hospital
Hong Kong, 000000
Boehringer Ingelheim, 800965365, hongkong@bitrialsupport.com
Recruiting
Queen Mary Hospital
Hong Kong
Boehringer Ingelheim, 800965365, hongkong@bitrialsupport.com
Recruiting

Other trials in Hong Kong

Netherlands2 sites, 2 recruiting

Amsterdam UMC Locatie AMC
Amsterdam, 1105 AZ
Boehringer Ingelheim, 08000204613, nederland@bitrialsupport.com
Not yet recruiting
Universitair Medisch Centrum Groningen
Groningen, 9713 GZ
Boehringer Ingelheim, 08000204613, nederland@bitrialsupport.com
Recruiting

Other trials in Netherlands

Saudi Arabia2 sites, 2 recruiting

King Fahad Specialist Hospital - Research Center
Dammam, 31444
Boehringer Ingelheim, 8001263002, saudi@bitrialsupport.com
Not yet recruiting
Imam Abdulrahman bin Faisal University
Dammam, 34221
Boehringer Ingelheim, 8001263002, saudi@bitrialsupport.com
Not yet recruiting

Other trials in Saudi Arabia

Switzerland2 sites, 2 recruiting

University Hospital Bern
Bern, 3010
Boehringer Ingelheim, 0800005900, suisse@bitrialsupport.com
Recruiting
University Hospital Zurich
Zurich, 8091
Boehringer Ingelheim, 0800005900, suisse@bitrialsupport.com
Not yet recruiting

Other trials in Switzerland

Thailand2 sites, 2 recruiting

King Chulalongkorn Memorial Hospital
Bangkok, 10330
Boehringer Ingelheim, 1800019059, thai@bitrialsupport.com
Recruiting
Maharaj Nakom Chiangmai Hospital
Chiang Mai, 50200
Boehringer Ingelheim, 1800019059, thai@bitrialsupport.com
Recruiting

Other trials in Thailand

Estonia1 site, 1 recruiting

North Estonia Medical Centre Foundation, Tallinn
Tallinn, 13419
Boehringer Ingelheim, 8000044842, eesti@bitrialsupport.com
Not yet recruiting

Other trials in Estonia

Philippines1 site, 1 recruiting

Manila Doctors Hospital
Manila, 1000
Boehringer Ingelheim, 180084748502, pilipinas@bitrialsupport.com
Not yet recruiting

Other trials in Philippines

About this study

Official title: A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial to Assess the Effects of Oral TRPC6 Inhibitor BI 764198 Taken Over a 104 Week Treatment Period in Adult and Adolescent Participants With Primary Focal Segmental Glomerulosclerosis (pFSGS) or Genetic FSGS Related to TRPC6 Gene Variants

PODOMOUNT-pFSGS

This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 helps people with FSGS.

Participants are put into 2 groups randomly, which means by chance. Every participant has an equal chance of being in each group. One group takes BI 764198 tablets, and the other group takes placebo tablets. Placebo tablets look like BI 764198 tablets but do not contain any medicine.

Participants take a tablet once a day for up to 2 years. All participants also continue their standard medication for FSGS.

Participants are in the study for up to 2 years. During this time, they visit the study site about every 3 months. Participants regularly collect urine samples. This is done to check their kidneys. The results are compared between the two groups to see whether the treatment works. The doctors also regularly check participants' health and take note of any unwanted effects.

Conditions: Focal Segmental Glomerulosclerosis
Being tested: BI 764198, Placebo
Medical subject headings: Glomerulosclerosis, Focal Segmental

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

BI 764198Drug
Also called Apecotrep
BI 764198
PlaceboDrug
Placebo matching BI 764198

Study groups in NCT07220083
Study group	Role	What they receive
BI 764198 treatment	Experimental	Not described Receives: Drug: BI 764198
Placebo treatment	Experimental	Not described Receives: Drug: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

Relative change in 24-hour UPCR (measured in mg/g) from baseline to Week 104
24-hour urinary protein-to-creatinine ratio (24-hr UPCR)
Measured: Baseline and Week 104

Secondary outcomes (6)

Key secondary endpoint: Absolute change in eGFRcys in mL/min/1.73m2 from baseline to Week 104
Estimated glomerular filtration rate based on serum cystatin C (eGFRcys)
Measured: Baseline and Week 104
Key secondary endpoint: Treatment response, defined as 24-hr UPCR <1000 mg/g at Week 104
24-hour urinary protein-to-creatinine ratio (24-hr UPCR)
Measured: At Week 104
Treatment response, defined as 24-hr UPCR <1000 mg/g and eGFRcys ≥85% vs. baseline at Week 104 and no treatment failure between randomisation and Week 104 (combined or multi-component endpoint)
Treatment failure defined as:
Use of rescue therapy (treatment escalation):
- Worsening or severely active disease resulting in investigator-determined treatment failure and requiring rescue therapy (treatment escalation) during the trial. Treatment escalation includes initiation of a new medication or intensification of existing therapy, including an increase in the dose or target peak/trough level of selected concomitant medications (immunosuppressive therapies). Examples of intensification of immunosuppressive therapies used at screening, include:
- calcineurin inhibitors (CNIs)
- anti-metabolites (azathioprine, mycophenolate mofetil)
- cytotoxic agents (cyclophosphamide, chlorambucil)
- glucocorticoids, including escalation of prednisolone to ≥20 mg/day (oral or intravenous), or equivalent, for >14 days for treatment of kidney disease.
Measured: At Week 104
Complete remission, defined as 24-hr UPCR <300 mg/g at Week 104
24-hour urinary protein-to-creatinine ratio (24-hr UPCR)
Measured: At Week 104
Change from baseline across disease-specific clinical outcome assessment (COA) NS-SIM-PRO at Week 104
The nephrotic syndrome swelling impact measure (NS-SIM-PRO) has 23 items covering physical function (e.g. mobility), physical symptoms (e.g. fatigue, nausea), and essential function (e.g. vision) impacts identified as being important aspects of participants' experiences with nephrotic-syndrome related swelling.
It is expected that all item responses will be combined to generate a single score representing overall swelling impact.
The score ranges from 0 up to 4 (0 = never, 1 = almost never, 2 = sometimes, 3 = often, 4 = almost always). A lower score on any of the NS-SIM-PRO subscales indicate a better quality of life.
Measured: Baseline and Week 104
Change from baseline across clinical outcome assessment (COA) KDQOL-36 at Week 104
Kidney disease quality of life 36-item short form survey (KDQOL-36) assessing the health-related quality of life (HRQOL) in adult participants with kidney disease. It combines the generic SF-12 Health Survey with additional items specifically relevant to kidney disease.
Key Components:
- SF-12 Health Survey: Includes 12 items that measure physical and mental health, providing a broad overview of the patient's general health status.
- Burden of Kidney Disease: This subscale (4 items) assesses how much kidney disease interferes with daily life and causes frustration.
- Symptoms/Problems: This subscale (12 items) evaluates the frequency and severity of symptoms related to kidney disease, such as pain, fatigue, and sleep disturbances.
- Effects of Kidney Disease: This subscale (8 items) measures the impact of kidney disease on daily activities and overall well-being.
The score ranges from 0 up to 6 and a higher score on most of the KDQOL-36 subscales indicate a better quality of life.
Measured: Baseline and Week 104

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

16 Feb 202624 Jan 2029

First posted23 Oct 2025
Study start16 Feb 2026
Primary completion27 Dec 2028 (estimated)
Study completion24 Jan 2029 (estimated)

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for Focal Segmental GlomerulosclerosisStudies of the same condition, open and under way.
More trials run by Boehringer IngelheimThe sponsor's other registered studies.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase 3
Primary purpose: Treatment
Allocation: Randomised
Intervention model: Parallel groups
Masking: Quadruple blind
Who is masked: Participant, Care provider, Investigator, Outcomes assessor
Enrolment: 286 participants (estimated)

IDs, dates and publications

ClinicalTrials.gov ID: NCT07220083
Sponsor's protocol ID: 1434-0017
Other IDs: 2025-522191-86-00, U1111-1326-1647, 2025
Status last verified: Oct 2026
First submitted: 22 Oct 2025
Last updated: 14 Oct 2026
Results posted: No
Data monitoring committee: No
FDA-regulated drug: Yes
FDA-regulated device: No
Individual data sharing: Yes: Once the criteria in section 'time frame' are fulfilled, researchers can use the following link https://www.clinicalstudies.boehringer-ingelheim.com/msw/datasharing to request access to the clinical study documents regarding this study, and upon a signed "Document Sharing Agreement". Furthermore, researchers can request access to the clinical study data, for this and other listed studies, after the submission of a research proposal and according to the terms outlined in the website.

Interested in taking part?

Boehringer Ingelheim

1-800-243-0127

clintriage.rdg@boehringer-ingelheim.com

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See sites and contacts

RecruitingPhase 2
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases
Focal Segmental Glomerulosclerosis, Minimal Change Disease
Not yet recruitingObservational study
MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)
Antiphospholipid (aPL)-Positive, Rheumatic Arthritis
RecruitingPhase 2
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion
Not yet recruitingPhase 2
A Study to Evaluate the Effectiveness and Safety of Sibeprenlimab in Participants With Primary Membranous Nephropathy, Immune-mediated Focal Segmental Glomerulosclerosis, and Minimal Change Disease
Primary Membranous Nephropathy, Minimal Change Disease
RecruitingPhase 2
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis

All Focal Segmental Glomerulosclerosis trials

Study at a glance

From the registry record, last updated by the sponsor on 14 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial to Assess the Effects of Oral TRPC6 Inhibitor BI 764198 Taken Over a 104 Week Treatment Period in Adult and Adolescent Participants With Primary Focal Segmental Glomerulosclerosis (pFSGS) or Genetic FSGS Related to TRPC6 Gene Variants
ClinicalTrials.gov ID: NCT07220083
Acronym / sponsor ID: 1434-0017
Conditions: Focal Segmental Glomerulosclerosis
Phase: Phase 3
Study type: Interventional
Recruitment status: Recruiting
Enrolment: 286 participants (estimated)
Lead sponsor: Boehringer IngelheimIndustry (pharma, biotech, devices)
Study start: 16 Feb 2026 (actual)
Primary completion: 27 Dec 2028 (estimated)
Study completion: 24 Jan 2029 (estimated)
First posted: 23 Oct 2025 (actual)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

PODOMOUNT-pFSGS

Participants take a tablet once a day for up to 2 years. All participants also continue their standard medication for FSGS.

Study design

Primary purpose: Treatment
Allocation: Randomised
Intervention model: Parallel groups
Masking: Quadruple blind (participant, care provider, investigator, outcomes assessor)
Number of arms: 2

Arm	Type	Receives
BI 764198 treatment	Experimental	Drug: BI 764198
Placebo treatment	Experimental	Drug: Placebo

Who may qualify

Ages: 12 years and older
Sex: All
Healthy volunteers: Not accepted
Age groups: Child, Adult, Older adult

Key inclusion criteria (10 listed)

Male or female participants ≥12 years old on the day of signing informed consent/assent (Visit 1)
Weight of ≥40 kg at the screening visit (Visit 1)
Body mass index (BMI) of ≤40 kg/m² at the screening visit (Visit 1)
Participants with a diagnosis prior to the screening visit (Visit 1) of either:
Urine protein-creatinine ratio (UPCR) ≥1500 mg/g based on the mean of the spot urine sample and first morning void (FMV) urine sample (both assessed by central laboratory) at the screening visit (Visit 1)

Key exclusion criteria (5 listed)

Known monogenic or syndromic causes of FSGS (with the exception of TRPC6 gain-of-function gene mutations)
Clinical or histologic evidence of secondary adaptive or toxic forms of FSGS (based on Investigator's judgement)
FSGS of undetermined cause (FSGS-UC) with a diagnosis prior to the screening visit (Visit 1) (based on Investigator's judgement)
A history of organ transplantation or planned organ transplantation during the course of the trial
Use of intravenous immunosuppressive agents (e.g. cyclophosphamide, rituximab, obinutuzumab) in the last 6 months prior to screening (Visit 1) Further exclusion criteria apply.

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
BI 764198Also: ApecotrepBI 764198	Drug	BI 764198 treatment
PlaceboPlacebo matching BI 764198	Drug	Placebo treatment

Primary outcome

Relative change in 24-hour UPCR (measured in mg/g) from baseline to Week 104
Time frame: Baseline and Week 104
24-hour urinary protein-to-creatinine ratio (24-hr UPCR)

6 secondary outcomes

Key secondary endpoint: Absolute change in eGFRcys in mL/min/1.73m2 from baseline to Week 104
Time frame: Baseline and Week 104
Key secondary endpoint: Treatment response, defined as 24-hr UPCR <1000 mg/g at Week 104
Time frame: At Week 104
Treatment response, defined as 24-hr UPCR <1000 mg/g and eGFRcys ≥85% vs. baseline at Week 104 and no treatment failure between randomisation and Week 104 (combined or multi-component endpoint)
Time frame: At Week 104
Complete remission, defined as 24-hr UPCR <300 mg/g at Week 104
Time frame: At Week 104
Change from baseline across disease-specific clinical outcome assessment (COA) NS-SIM-PRO at Week 104
Time frame: Baseline and Week 104
Change from baseline across clinical outcome assessment (COA) KDQOL-36 at Week 104
Time frame: Baseline and Week 104

Results and safety

This study is still under way. Results are not available in the source record yet.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 14 Oct 2026.
Related InfoLink provided by the sponsor.
Individual participant dataSharing planned: Yes. Once the criteria in section 'time frame' are fulfilled, researchers can use the following link https://www.clinicalstudies.boehringer-ingelheim.com/msw/datasharing to request access to the clinical study documents regarding this study, and upon a signed "Document Sharing Agreement". Furthermore, researchers can request access to the clinical study data, for this and other listed studies, after the submission of a research proposal and according to the terms outlined in the website.

Related trials for Focal Segmental Glomerulosclerosis

RecruitingPhase 2
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases
Focal Segmental Glomerulosclerosis, Minimal Change Disease
Not yet recruitingObservational study
MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)
Antiphospholipid (aPL)-Positive, Rheumatic Arthritis
RecruitingPhase 2
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion
Not yet recruitingPhase 2
A Study to Evaluate the Effectiveness and Safety of Sibeprenlimab in Participants With Primary Membranous Nephropathy, Immune-mediated Focal Segmental Glomerulosclerosis, and Minimal Change Disease
Primary Membranous Nephropathy, Minimal Change Disease
RecruitingPhase 2
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.

Boehringer Ingelheim contact

1-800-243-0127

clintriage.rdg@boehringer-ingelheim.com

316 sites in 40 countries: see every site and its status.

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing BI 764198 in people with Focal Segmental Glomerulosclerosis, run by Boehringer Ingelheim at 316 sites in 40 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 14 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 316 sites in United States, China, India, Japan, Turkey (Türkiye) and 35 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Boehringer Ingelheim (1-800-243-0127, clintriage.rdg@boehringer-ingelheim.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Relative change in 24-hour UPCR (measured in mg/g) from baseline to Week 104 (time frame: Baseline and Week 104). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07220083.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2026.